KENALOG-40 INJECTION 40 MG — DIN 01999869
TRIAMCINOLONE ACETONIDE : 40 MG · BRISTOL-MYERS SQUIBB CANADA · SUSPENSION · wholesale supply in Canada
Health Canada status: MARKETED
What is KENALOG-40 INJECTION?
KENALOG-40 INJECTION 40 MG contains TRIAMCINOLONE ACETONIDE : 40 MG. It is listed in the Health Canada Drug Product Database under DIN 01999869, held by BRISTOL-MYERS SQUIBB CANADA, supplied as SUSPENSION for INTRA-ARTICULAR ; INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 23-Nov-2010. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is KENALOG-40 INJECTION used for?
Intramuscular (I.M.) administration is indicated for systemic corticosteroid therapy in conditions such as dermatoses, generalized rheumatoid arthritis, and other connective tissue disorders. It is also indicated for allergic diseases, with epinephrine being the drug of choice for acute allergic reactions and steroid therapy being adjunctive. I.M. administration is particularly valuable when oral corticosteroid therapy is not feasible. Intra-articular or intrabursal administration, and injections into tendon sheaths, are indicated as adjunctive therapy for short-term administration in conditions including synovitis of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, acute nonspecific tenosynovitis, and post-traumatic osteoarthritis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Triamcinolone cost around the world?
Triamcinolone is listed on 6 of the national price registers Nexara ingests. Each country publishes on a different basis, so figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Czechia publishes a max producer price (ex-factory); Hungary publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed |
|---|---|---|---|
| Austria | KVP (Kassenverkaufspreis) | 8 | 13 |
| Hungary | producer price (ex-factory) | 2 | 2 |
| Romania | max producer price | 1 | 2 |
| Czechia | max producer price (ex-factory) | 1 | 1 |
| Iceland | max wholesale | 1 | 1 |
| Luxembourg | reimbursement | 1 | 1 |
20 pack listings across 14 brand entries and 6 price bases, refreshed 05 Sep 2026. Ranges span every Triamcinolone pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Triamcinolone in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
9 holders have a Canadian DIN containing Triamcinolone, across 21 DINs, of which 3 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB CANADA | 2 | 2 | KENALOG-10 INJECTION, KENALOG-40 INJECTION | Sourceable in Canada |
| STERIMAX INC | 2 | 1 | TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP, TRIAMCINOLONE DIACETATE SUSPENSION | Sourceable in Canada |
| LEDERLE CYANAMID CANADA INC. | 6 | 0 | ARISTOCORT FORTE INJ 40MG/ML, ARISTOCORT INJ INTRALESIONAL 25MG/ML, ARISTOCORT SYR 2MG/5ML, ARISTOCORT TAB 2MG, ARISTOCORT TAB 4MG, +1 more | No marketed DIN |
| GLADES, DIVISION OF STIEFEL CANADA INC. | 5 | 0 | ARISTOCORT - SYR ORL 0.4MG/ML, ARISTOCORT - TAB 4MG, ARISTOCORT FORTE - LIQ IA IM ISY 40MG/ML, ARISTOCORT INJ INTRALESIONAL-25MG/ML, ARISTOCORT-TAB 2MG | No marketed DIN |
| SANDOZ CANADA INCORPORATED | 2 | 0 | TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP | No marketed DIN |
| MEDEXUS PHARMACEUTICALS INC. | 1 | 0 | TRISPAN | No marketed DIN |
| SCHEIN PHARMACEUTICAL CANADA INC. | 1 | 0 | SCHEINPHARM TRIAMCINE-A INJECT.SUS-40MG/ML | No marketed DIN |
| TARO PHARMACEUTICALS INC | 1 | 0 | TRIAMCINOLONE DIACETATE SUS 40MG/ML | No marketed DIN |
| VALEO PHARMA INC | 1 | 0 | ARISTOSPAN | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 40 MG |
|---|---|
| Dosage form | SUSPENSION |
| Route | INTRA-ARTICULAR ; INTRAMUSCULAR |
| Pack configuration (monograph) | Vials of 1 and 5 mL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Triamcinolone |
|---|---|
| ATC code | H02AB08 |
| AHFS class | 68:04.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01999869 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1999869 |
| Brand name | KENALOG-40 INJECTION |
| Generic / active ingredient | TRIAMCINOLONE ACETONIDE : 40 MG |
| Market authorization holder | BRISTOL-MYERS SQUIBB CANADA |
| Health Canada schedule | Prescription |
| ATC code | H02AB08 |
| ATC anatomical main group | H — Systemic hormonal preparations |
| ATC therapeutic subgroup | H02AB |
| Current status | MARKETED |
| Status date | 23-Nov-2010 |
| Original market date | 1973-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
3 of 21 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| KENALOG-10 INJECTION | 10 MG | SUSPENSION | BRISTOL-MYERS SQUIBB CANADA | MARKETED | 01999761 |
| TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP | 40 MG | SUSPENSION | STERIMAX INC | MARKETED | 01977563 |
| ARISTOCORT - SYR ORL 0.4MG/ML | .4 MG | SYRUP | GLADES, DIVISION OF STIEFEL CANADA INC. | CANCELLED POST MARKET | 02194139 |
| ARISTOCORT - TAB 4MG | 4 MG | TABLET | GLADES, DIVISION OF STIEFEL CANADA INC. | CANCELLED POST MARKET | 02194090 |
| ARISTOCORT FORTE - LIQ IA IM ISY 40MG/ML | 40 MG | LIQUID | GLADES, DIVISION OF STIEFEL CANADA INC. | CANCELLED POST MARKET | 02194120 |
| ARISTOCORT FORTE INJ 40MG/ML | 40 MG | LIQUID | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00014842 |
| ARISTOCORT INJ INTRALESIONAL 25MG/ML | 25 MG | LIQUID | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00014834 |
| ARISTOCORT INJ INTRALESIONAL-25MG/ML | 25 MG | LIQUID | GLADES, DIVISION OF STIEFEL CANADA INC. | CANCELLED POST MARKET | 02194147 |
| ARISTOCORT SYR 2MG/5ML | 2 MG / 5 ML | SYRUP | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00014893 |
| ARISTOCORT TAB 2MG | 2 MG | TABLET | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | 00015016 |
2 · Same class — other molecules in ATC H02AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Dexamethasone | APO-DEXAMETHASONE · DECADRON PHOSPHATE INJ 4MG/ML · DECADRON TAB 0.5MG · DECADRON TAB 4MG · +24 more | 42 | 13 | Yes |
| Methylprednisolone | DEPO-MEDROL · MEDROL · METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP · METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(80MG/ML WITH PRESERVATIVE) · +7 more | 34 | 13 | Yes |
| Hydrocortisone | A-HYDROCORT INJ 1000MG/8ML · A-HYDROCORT INJ 100MG/2ML · A-HYDROCORT INJ 250MG/2ML · A-HYDROCORT INJ 500MG/4ML · +6 more | 18 | 8 | Yes |
| Prednisone | ALTI-PREDNISONE TAB 5MG · APO PREDNISONE TAB 1MG USP · APO PREDNISONE TAB 50MG · APO PREDNISONE TAB 5MG · +11 more | 19 | 5 | Yes |
| Triamcinolone | ARISTOCORT - SYR ORL 0.4MG/ML · ARISTOCORT - TAB 4MG · ARISTOCORT FORTE - LIQ IA IM ISY 40MG/ML · ARISTOCORT FORTE INJ 40MG/ML · +15 more | 21 | 3 | Yes |
| Betamethasone | BETAJECT · BETNESOL TAB 0.5MG · BETNESOL TABLETS · CELESTONE REPETABS 1MG · +2 more | 6 | 1 | Yes |
| Prednisolone | NOVO-PREDNISOLONE 5MG · PEDIAPRED · PEDIAPRED - LIQ 6.7MG/5ML · PMS-PREDNISOLONE | 4 | 1 | Yes |
| Cortisone | CORTISONE ACETATE · CORTONE SUS 50MG/ML · CORTONE TAB 25MG · CORTONE TAB 5MG | 4 | 1 | Yes |
| Prednisone, Combinations | METRETON TAB | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC H02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| H02AA | Fludrocortisone | 3 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is KENALOG-40 INJECTION called?
Also recorded in Canada as: {1 (118 ML) (dimethicone 20 MG/ML Topical Cream) / 1 (80000 MG) (triamcinolone acetonide 1 MG/ML Topical Cream) } Pack (US), triamcinolone acetonide 0.147 MG/ML Topical Spray [Kenalog] (US), triamcinolone acetonide 10 MG/ML Injectable Suspension [Kenalog] (US), triamcinolone acetonide 40 MG/ML Injectable Suspension [Kenalog] (US), triamcinolone acetonide 0.001 MG/MG Oral Paste [Oralone] (US), triamcinolone acetonide 1 MG/ML Topical Cream [Triderm] (US), 1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence] (US), triamcinolone acetonide 0.0005 MG/MG Topical Ointment [Trianex] (US), triamcinolone acetonide 0.25 MG/ML Topical Cream [Triderm] (US), triamcinolone acetonide 5 MG/ML Topical Cream [Triderm] (US), triamcinolone acetonide 0.05 MG/ACTUAT Metered Dose Nasal Spray [AllerNaze] (US), triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray [Nasacort] (US), triamcinolone acetonide 0.15 MG/ML Topical Spray [Genesis] (US), triamcinolone acetonide 32 MG Injection [Zilretta] (US), triamcinolone acetonide 80 MG/ML Injectable Suspension [Kenalog] (US).
The same molecule, Triamcinolone, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Dermanolon | Latin | Iceland |
| TRISPAN | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Triamcinolone called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Triamcinolone, published to help those searches reach this page.
| Language | Triamcinolone |
|---|---|
| Portuguese Português | Triancinolona |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.